Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment ; volume:12 ; number:1 ; day:10 ; month:8 ; year:2012 ; pages:1-5 ; date:12.2012
BMC psychiatry ; 12, Heft 1 (10.8.2012), 1-5, 12.2012
- Urheber
-
Barak, Yoram
- Beteiligte Personen und Organisationen
-
Aizenberg, Dov
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-12-108
- URN
-
urn:nbn:de:1111-2016030434267
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barak, Yoram
- Aizenberg, Dov
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Psychosocial interventions in schizophrenia : an internat. view
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
Updated rationale for the initial antipsychotic selection for patients with schizophrenia
A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Psychosocial interventions in schizophrenia : an internat. view
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
Updated rationale for the initial antipsychotic selection for patients with schizophrenia
A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Psychosocial interventions in schizophrenia : an internat. view
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
Updated rationale for the initial antipsychotic selection for patients with schizophrenia